[Functional morphology of mediator systems of the brain].
Otellin
V A
VA
D000328:Adult; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology; D015306:Biogenic Monoamines / Q000502:physiology; D001921:Brain / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure*; D002395:Catecholamines / Q000502:physiology; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure; D004298:Dopamine / Q000502:physiology; D006801:Humans; D007395:Interneurons / Q000502:physiology; D018377:Neurotransmitter Agents / Q000502:physiology*; D010300:Parkinson Disease / Q000503:physiopathology; D011619:Psychotropic Drugs / Q000494:pharmacology; D017983:Receptors, Catecholamine / Q000502:physiology; D011954:Receptors, Dopamine / Q000502:physiology; D017981:Receptors, Neurotransmitter / Q000502:physiology; D013569:Synapses / Q000502:physiology; D009435:Synaptic Transmission / Q000502:physiology
D000928:Antidepressive Agents; D015306:Biogenic Monoamines; D002395:Catecholamines; D018377:Neurotransmitter Agents; D011619:Psychotropic Drugs; D017983:Receptors, Catecholamine; D011954:Receptors, Dopamine; D017981:Receptors, Neurotransmitter; D004298:Dopamine
Funktsional'naia morfologiia mediatornykh sistem golovnogo mozga.